Generate Biomedicines, Inc. (GENB) vs Sarepta Therapeutics, Inc. (SRPT)
A side-by-side comparison of Generate Biomedicines, Inc. and Sarepta Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
GENB
Generate Biomedicines, Inc.
$14.07HealthcareDelayed quote: Oct 6, 2026, 1:30 PM EDT
SRPT
Sarepta Therapeutics, Inc.
$17.12HealthcareDelayed quote: Oct 6, 2026, 1:25 PM EDT
Total return — GENB vs SRPT
growth of $100 · dividends reinvested · last 1yGENB +10.0% (+10.0%/yr)SRPT -3.5% (-3.5%/yr)GENB compounded faster over this window
GENB SRPT
GENB vs SRPT: by the numbers
- •SRPT is the larger company ($1.81B vs $1.80B market cap).
- •Both run net losses; SRPT's is the smaller (-6.93% vs -636.99% net margin).
Metrics side by side
Valuation
| Metric | GENB | SRPT |
|---|---|---|
| Forward P/E | N/A | 5.32 |
| P/S ratio | N/A | 0.92 |
| P/B ratio | 3.96 | 1.18 |
Profitability
| Metric | GENB | SRPT |
|---|---|---|
| Gross margin | 100.00% | 58.56% |
| Operating margin | -737.04% | -29.92% |
| Net margin | -636.99% | -6.93% |
| ROE | N/A | -8.95% |
| ROIC | -94.79% | -5.33% |
Growth (annualized)
| Metric | GENB | SRPT |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 26.90% |
| Total return CAGR (5Y) | N/A | -28.74% |
Go deeper
Dig into the metrics
Generate Biomedicines ROESarepta Therapeutics ROEGenerate Biomedicines operating marginSarepta Therapeutics operating marginGenerate Biomedicines revenue growthSarepta Therapeutics revenue growthGenerate Biomedicines free cash flowSarepta Therapeutics free cash flow
Generate Biomedicines & Sarepta Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.